or
forgot password
  • cancer clinical trials in omaha, NE

  • Combination Chemotherapy and Bevacizumab in Treating Women With HER2/Neu-Negative Stage II or Stage III Breast Cancer
    UNMC Eppley Cancer Center at the University of Nebraska Medical Center
    Omaha, Nebraska 68198-7680
    HER2-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer
    A Phase 1 Safety Study of LY2127399 in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma
    University of Nebraska Medical Center
    Omaha, Nebraska 68198-3330
    Relapsed or Refractory Multiple Myeloma
    Collaborative Registry of Patients With Thyroid Cancer and/or Thyroid Tumors
    Clinical Trials Patient Advocate Office
    Omaha, Nebraska 68198
    Neoplasms, Thyroid
    Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    University of Nebraska Medical Center

    Trial Locations
    University of Nebraska Medical Center
    Methodist Estabrook Cancer Center
    Creighton University Medical Center
    Alegent Health Immanuel Medical Center
    Alegent Health Bergan Mercy Medical Center
    Missouri Valley Cancer Consortium CCOP
    Alegent Health Lakeside Hospital
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Diet and Physical Activity Change or Usual Care in Improving Survival in Patients With Previously Treated Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Methodist Estabrook Cancer Center
    Omaha, Nebraska 68114-4199
    Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer, Weight Changes
    American Ginseng in Treating Patients With Fatigue Caused by Cancer
    CCOP - Missouri Valley Cancer Consortium

    Trial Locations
    CCOP - Missouri Valley Cancer Consortium
    Immanuel Medical Center
    Creighton University Medical Center
    Alegant Health Cancer Center at Bergan Mercy Medical Center
    Chronic Myeloproliferative Disorders, Fatigue, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Precancerous Condition, Unspecified Adult Solid Tumor, Protocol Specific
    Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
    University of Nebraska Medical Center
    Omaha, Nebraska 68198-3330
    Renal Cell Carcinoma
    Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
    Nebraska Methodist Cancer Center
    Omaha, Nebraska 68114
    Carcinoma
    Bevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the Ovary
    Methodist Estabrook Cancer Center
    Omaha, Nebraska 68114-4199
    Ovarian Stromal Cancer
    Efficacy and Safety Study of OncoVEXGM-CSF Compared to GM-CSF in Melanoma
    Methodist Estabrook Cancer Center
    Omaha, Nebraska 68114-4199
    Melanoma
    Neuropsychological and Behavioral Testing in Young Patients With Cancer
    University of Nebraska Medical Center
    Omaha, Nebraska 68198-3330
    Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Unspecified Childhood Solid Tumor, Protocol Specific
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Methodist Estabrook Cancer Center

    Trial Locations
    Methodist Estabrook Cancer Center
    Creighton University Medical Center
    Alegent Health Immanuel Medical Center
    Alegent Health Bergan Mercy Medical Center
    Missouri Valley Cancer Consortium CCOP
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
    University of Nebraska Medical Center

    Trial Locations
    University of Nebraska Medical Center
    Methodist Estabrook Cancer Center
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
    CCOP - Missouri Valley Cancer Consortium

    Trial Locations
    CCOP - Missouri Valley Cancer Consortium
    Immanuel Medical Center
    Creighton University Medical Center
    Alegant Health Cancer Center at Bergan Mercy Medical Center
    Lakeside Hospital
    Lung Cancer
    Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors
    Children's Hospital and Medical Center of Omaha
    Omaha, Nebraska 68114
    Adult Rhabdomyosarcoma, Adult Synovial Sarcoma, Childhood Hepatoblastoma, Childhood Synovial Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Adrenocortical Carcinoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Liver Cancer, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Neuroblastoma, Recurrent Osteosarcoma, Recurrent Retinoblastoma, Recurrent Wilms Tumor and Other Childhood Kidney Tumors
    Axitinib (AG-013736) With Or Without Dose Titration (Increase) In Patients With Kidney Cancer
    Pfizer Investigational Site
    Omaha, Nebraska 68198
    Carcinoma, Renal Cell
    Topotecan and Doxorubicin in Treating Patients With Small Cell Lung Cancer That Has Relapsed or Not Responded to Treatment
    UNMC Eppley Cancer Center at the University of Nebraska Medical Center
    Omaha, Nebraska 68198-7680
    Recurrent Small Cell Lung Cancer
    Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer
    CCOP - Missouri Valley Cancer Consortium

    Trial Locations
    CCOP - Missouri Valley Cancer Consortium
    Methodist Estabrook Cancer Center
    Immanuel Medical Center
    Creighton University Medical Center
    Alegant Health Cancer Center at Bergan Mercy Medical Center
    Lung Cancer
    Ixabepilone and Cyclophosphamide as Neoadjuvant Therapy in HER-2 Negative Breast Cancer
    Methodist Cancer Center
    Omaha, Nebraska 68114
    Breast Cancer
    Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
    CCOP - Missouri Valley Cancer Consortium

    Trial Locations
    CCOP - Missouri Valley Cancer Consortium
    UNMC Eppley Cancer Center at the University of Nebraska Medical Center
    Immanuel Medical Center
    Creighton University Medical Center
    Alegant Health Cancer Center at Bergan Mercy Medical Center
    Lakeside Hospital
    Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
    S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
    CCOP - Missouri Valley Cancer Consortium

    Trial Locations
    CCOP - Missouri Valley Cancer Consortium
    Immanuel Medical Center
    Creighton University Medical Center
    Alegant Health Cancer Center at Bergan Mercy Medical Center
    Lakeside Hospital
    Breast Cancer, Lung Cancer, Metastatic Cancer, Multiple Myeloma, Plasma Cell Neoplasm, Prostate Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
    CCOP - Missouri Valley Cancer Consortium

    Trial Locations
    CCOP - Missouri Valley Cancer Consortium
    Immanuel Medical Center
    Creighton University Medical Center
    Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific